India’s pharmaceutical companies went on a buying spree last year to win a bigger share of the U.S. market for generic drugs. Heightened American scrutiny of Indian facilities, and a desire to sell more sophisticated medicine in the U.S. is prompting many of these acquisitions.
from WSJ.com: US Business http://ift.tt/1QFDycI
via IFTTT
No comments:
Post a Comment